Fayed A S, Shehata M A, Hassan N Y, Weshahy S A
Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Egypt.
Pharmazie. 2007 Nov;62(11):830-5.
Validated stability-indicating spectrophotometric and spectrofluorimetric assays (SIAMs) were developed for the determination of alfuzosin hydrochloride (ALF) in the presence of its oxidative, acid, and alkaline degradation products. Three spectrophotometric methods were suggested for the determination of ALF in the presence of its oxidative degradation product; these included the use of zero order (0D), first order (1D), and third order (3D) spectra. The absorbance was measured at 330.8 nm for (0D) method, while the amplitude of first derivative (1D) method and that of third derivative (3D) method were measured at 354.0 and 241.2 nm, respectively. The linearity ranges were 1.0-40.0 microg/ml for (0D) and (1D) methods, and 1.0-10.0 microg/ml for (3D) method. Two spectrofluorimetric methods were developed, one for determination of ALF in the presence of its oxidative degradation product and the other for its determination in the presence of its acid or alkaline degradation products. The first method was based on measuring the native fluorescence of ALF in deionized water using lamda(excitation) 325.0 nm and lamda(emission) 390.0 nm. The linearity range was 50.0-750.0 ng/ml. This method was also used to determine ALF in human plasma with the aid of a suggested solid phase extraction method. The second method was used for determination of ALF via its acid degradation product. The method was based on the reaction of fluorescamine with the primary aliphatic amine group produced on the degradation product moiety. The reaction product was determined spectrofluorimetrically using lamda(excitation) 380.0 nm and lamda(emission) 465.0 nm. The linearity range was 100.0-900.0 ng/ml. All methods were validated according to the International Conference on Harmonization (ICH) guidelines, and applied to bulk powder and pharmaceutical formulations.
已开发出经过验证的稳定性指示分光光度法和荧光分光光度法(SIAMs),用于在存在氧化、酸和碱降解产物的情况下测定盐酸阿夫唑嗪(ALF)。提出了三种分光光度法用于在存在氧化降解产物的情况下测定ALF;这些方法包括使用零阶(0D)、一阶(1D)和三阶(3D)光谱。对于(0D)法,在330.8 nm处测量吸光度,而对于一阶导数(1D)法和三阶导数(3D)法,分别在354.0和241.2 nm处测量振幅。(0D)和(1D)法的线性范围为1.0 - 40.0 μg/ml,(3D)法的线性范围为1.0 - 10.0 μg/ml。开发了两种荧光分光光度法,一种用于在存在氧化降解产物的情况下测定ALF,另一种用于在存在酸或碱降解产物的情况下测定ALF。第一种方法基于在去离子水中使用λ(激发)325.0 nm和λ(发射)390.0 nm测量ALF的天然荧光。线性范围为50.0 - 750.0 ng/ml。该方法还借助建议的固相萃取方法用于测定人血浆中的ALF。第二种方法用于通过其酸降解产物测定ALF。该方法基于荧光胺与降解产物部分产生的伯脂肪胺基团的反应。使用λ(激发)380.0 nm和λ(发射)465.0 nm通过荧光分光光度法测定反应产物。线性范围为100.0 - 900.0 ng/ml。所有方法均根据国际协调会议(ICH)指南进行了验证,并应用于原料药粉末和药物制剂。